Conditions: Gastrointestinal Problems Autism Spectrum Disorders
Keywords: children
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 18
Healthy volunteers: no

Brief summary:
This is an open-label clinical trial to investigate a combination therapy for treating gastrointestinal problems in children with autism spectrum disorders.

The combination therapy includes beneficial bacteria.

Detailed description:
This is an open-label clinical trial to evaluate the safety, tolerability, and feasibility of a combination therapy to treat gastrointestinal problems in children with autism spectrum disorders.

It involves a combination therapy including beneficial bacteria.

Arms:
arm 1: This group will receive all treatments orally. The treatments include a combination of Vancomycin, MoviPrep, Prilosec, and human fecal material; processed, frozen. arm 2: This group will receive some treatments rectally and some orally. The treatments include a combination of Vancomycin, MoviPrep, Prilosec, and human fecal material; processed, frozen.

Interventions: intervention 1: oral Vancomycin intervention 2: MoviPrep intervention 3: Prilosec intervention 4: human fecal material; processed, frozen administered orally intervention 5: human fecal material; processed, frozen; administered orally and rectally
Intervention descriptions: intervention 1: an antibiotic intervention 2: a bowel cleanse intervention 3: a stomach acid suppressan intervention 4: human fecal material; processed, frozen, administered orally intervention 5: human fecal material; processed, frozen; administered orally and rectally

Protocol document: